who mdr tb treatment 2018?
Guideline Development Group (GDG) meeting - 16 to 20 July 2018. About 600,000 new cases of rifampicin-resistant or multidrug-resistant tuberculosis (MDR/RR-TB) are estimated to emerge each year, requiring treatment with second-line TB treatment regimens.